{
    "paper_id": "209d7a85764f38f4108bbedee5bc4a00a52ccf11",
    "metadata": {
        "title": "Journal Pre-proof Ictus isqu\u00e9mico e infecci\u00f3n por SARS-CoV-2, \u00bfasociaci\u00f3n casual o causal?",
        "authors": [
            {
                "first": "Jos\u00e9",
                "middle": [],
                "last": "Mar\u00eda Barrios-L\u00f3pez",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Iago",
                "middle": [],
                "last": "Rego-Garc\u00eda",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Claudia",
                "middle": [],
                "last": "Mu\u00f1oz Mart\u00ednez",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Juan",
                "middle": [],
                "last": "Carlos",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Romero-F\u00e1brega",
                "middle": [],
                "last": "Mar",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Rivero",
                "middle": [],
                "last": "Rodr\u00edguez",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Jes\u00fas",
                "middle": [],
                "last": "Antonio",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Ruiz",
                "middle": [],
                "last": "Gim\u00e9nez",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Francisco",
                "middle": [],
                "last": "Escamilla-Sevilla",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Adolfo M\u00ednguez-Castellanos",
                "middle": [],
                "last": "Mar\u00eda",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Dolores",
                "middle": [],
                "last": "Fern\u00e1ndez P\u00e9rez",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Mar\u00eda",
                "middle": [],
                "last": "Barrios-L\u00f3pez",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "J",
                "middle": [],
                "last": "Rego-Garc\u00eda",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Mart\u00ednez",
                "middle": [],
                "last": "Cm",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Romero-F\u00e1brega",
                "middle": [],
                "last": "Jc",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Rodr\u00edguez",
                "middle": [],
                "last": "Mr",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Gim\u00e9nez",
                "middle": [],
                "last": "Jar",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Escamilla-Sevilla F",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "M\u00ednguez-Castellanos",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Ictus isqu\u00e9mico e infecci\u00f3n por SARS-CoV-2, \u00bfasociaci\u00f3n casual o causal?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "T\u00cdTULO:"
        },
        {
            "text": "Introducci\u00f3n: Se ha comunicado la asociaci\u00f3n de ictus isqu\u00e9mico y COVID-19, con mayor frecuencia en aquellos pacientes m\u00e1s graves. Sin embargo, se desconoce en qu\u00e9 medida podr\u00eda estar en relaci\u00f3n con la inflamaci\u00f3n sist\u00e9mica e hipercoagulabilidad producidas en el contexto de la infecci\u00f3n.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "RESUMEN"
        },
        {
            "text": "M\u00e9todos: Descripci\u00f3n de cuatro pacientes atendidos en nuestro Centro por ictus isqu\u00e9mico y diagn\u00f3stico de COVID-19, clasific\u00e1ndolos seg\u00fan el grado de probabilidad causal entre el estado de hipercoagulabilidad y el ictus isqu\u00e9mico. Revisi\u00f3n de la literatura sobre los posibles mecanismos implicados en la etiopatogenia del ictus isqu\u00e9mico en este contexto.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "RESUMEN"
        },
        {
            "text": "Resultados: Dos pacientes se consideraron con alta probabilidad causal: presentaban infartos corticales, sin patolog\u00eda cardioemb\u00f3lica ni arterial significativa, con par\u00e1metros de inflamaci\u00f3n sist\u00e9mica e hipercoagulabilidad; las otras dos pacientes eran de edad avanzada y el ictus isqu\u00e9mico se consider\u00f3 cardioemb\u00f3lico, con una probable asociaci\u00f3n casual de COVID-19.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "RESUMEN"
        },
        {
            "text": "Conclusiones: La inflamaci\u00f3n sist\u00e9mica, junto con la posible acci\u00f3n directa del virus, provocar\u00eda disfunci\u00f3n endotelial, generando un estado de hipercoagulabilidad que podr\u00eda considerarse una causa potencial de ictus isqu\u00e9mico. Sin embargo, puesto que los mecanismos del ictus pueden ser m\u00faltiples, se precisan estudios m\u00e1s amplios que eval\u00faen esta hip\u00f3tesis. Mientras tanto, el estudio etiol\u00f3gico del ictus en pacientes con COVID-19 debe ser sistem\u00e1tico atendiendo a los protocolos vigentes, con las adaptaciones necesarias en relaci\u00f3n con las circunstancias cl\u00ednicas y epidemiol\u00f3gicas de la actual pandemia.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "RESUMEN"
        },
        {
            "text": "PALABRAS CLAVE: Alteraciones neurol\u00f3gicas; COVID-19; Covid-19; Hipercoagulabilidad; Ictus isqu\u00e9mico; Respuesta hiperinflamatoria; SARS; SARS-CoV-2; SARS2-CoV TITLE: Ischaemic stroke and SARS-CoV-2 infection: a causal or incidental association? ABSTRACT: Introduction: Ischaemic stroke has been reported in patients with COVID-19, particularly in more severe cases. However, it is unclear to what extent this is linked to systemic inflammation and hypercoagulability secondary to the infection. Materials and methods: We describe the cases of 4 patients with ischaemic stroke and COVID-19 who were attended at our hospital. Patients are classified according to the likelihood of a causal relationship between the hypercoagulable state and ischaemic stroke. We also conducted a review of studies addressing the possible mechanisms involved in the aetiopathogenesis of ischaemic stroke in these patients. Results: The association between COVID-19 and stroke was probably causal in 2 patients, who presented cortical infarcts and had no relevant arterial or cardioembolic disease, but did show signs of hypercoagulability and systemic inflammation in laboratory analyses. The other 2 patients were of advanced age and presented cardioembolic ischaemic stroke; the association in these patients was probably incidental. Conclusions: Systemic inflammation and the potential direct action of the virus may cause endothelial dysfunction, resulting in a hypercoagulable state that could be considered a potential cause of ischaemic stroke. However, stroke involves multiple pathophysiological mechanisms; studies with larger samples are therefore needed to confirm our hypothesis. The management protocol for patients with stroke and COVID-19 should include a complete aetiological study, with the appropriate safety precautions always being observed. Keywords: Neurological disorders; COVID-19; hypercoagulability; ischaemic stroke; SARS; SARS-CoV-2; SARS2-CoV ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "RESUMEN"
        },
        {
            "text": "En pacientes con enfermedad por coronavirus-2019 (COVID-19) se ha descrito la presencia de manifestaciones neurol\u00f3gicas (1), entre las cuales se encuentra el ictus isqu\u00e9mico (2, 3) . En una serie de 214 pacientes con COVID-19 hospitalizados en la ciudad china de Wuhan, el 2,8% presentaron ictus isqu\u00e9mico, 5,7% en el subgrupo de 88 pacientes con enfermedad m\u00e1s grave, los cuales presentaban niveles de d\u00edmero-D m\u00e1s elevados de forma significativa, plante\u00e1ndose el estado protromb\u00f3tico como posible etiolog\u00eda del ictus (2) . En un registro llevado a cabo por la Sociedad Espa\u00f1ola de Neurolog\u00eda (4) el ictus isqu\u00e9mico fue la segunda condici\u00f3n neurol\u00f3gica recogida con m\u00e1s frecuencia (22,8%) s\u00f3lo por debajo del s\u00edndrome confusional (28,3%). En una publicaci\u00f3n reciente, se comunicaron 3 pacientes con COVID-19 que presentaron ictus isqu\u00e9mico y que, adem\u00e1s de las manifestaciones anal\u00edticas t\u00edpicas de inflamaci\u00f3n sist\u00e9mica y d\u00edmero-D elevado, asociaban anticuerpos antifosfol\u00edpido (5).",
            "cite_spans": [
                {
                    "start": 174,
                    "end": 177,
                    "text": "(2,",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 178,
                    "end": 180,
                    "text": "3)",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 519,
                    "end": 522,
                    "text": "(2)",
                    "ref_id": "BIBREF0"
                }
            ],
            "ref_spans": [],
            "section": "INTRODUCCI\u00d3N"
        },
        {
            "text": "Con los datos disponibles actualmente, no queda claro en qu\u00e9 medida podr\u00eda existir una relaci\u00f3n de causalidad entre el estado protromb\u00f3tico asociado a COVID-19 y el ictus isqu\u00e9mico. Con el fin de contribuir a dilucidar esta cuesti\u00f3n, presentamos una serie de cuatro pacientes atendidos en nuestro Centro por ictus isqu\u00e9mico y COVID-19, adem\u00e1s de realizar una revisi\u00f3n de la literatura al respecto.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "INTRODUCCI\u00d3N"
        },
        {
            "text": "Descripci\u00f3n de cuatro pacientes consecutivos con ictus isqu\u00e9mico y COVID-19 atendidos entre el 25 de marzo y el 17 de abril de 2020 en un Hospital de referencia. Debido a la situaci\u00f3n de pandemia por SARS-CoV-2, la informaci\u00f3n a los pacientes y/o a sus representantes legales, as\u00ed como la aceptaci\u00f3n del consentimiento informado, se realiz\u00f3 verbalmente por v\u00eda telef\u00f3nica, tras la aprobaci\u00f3n por el Comit\u00e9 \u00c9tico de Investigaci\u00f3n Cl\u00ednica de Granada.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "M\u00c9TODOS"
        },
        {
            "text": "Se recogieron los siguientes grupos de variables: demogr\u00e1ficas/basales; relacionadas con la cl\u00ednica al ingreso y con la enfermedad COVID-19; relacionadas con el ictus isqu\u00e9mico; par\u00e1metros de laboratorio en el momento del ictus y evoluci\u00f3n cl\u00ednica. La etiolog\u00eda del ictus se estim\u00f3 siguiendo los criterios del sistema de clasificaci\u00f3n TOAST (6) . Los pacientes se clasificaron seg\u00fan el \"grado de causalidad\" estimado entre el estado de hipercoagulabilidad asociado a COVID-19 y el ictus.",
            "cite_spans": [
                {
                    "start": 341,
                    "end": 344,
                    "text": "(6)",
                    "ref_id": "BIBREF4"
                }
            ],
            "ref_spans": [],
            "section": "M\u00c9TODOS"
        },
        {
            "text": "A prop\u00f3sito de los casos descritos, realizamos una revisi\u00f3n bibliogr\u00e1fica sobre la posible relaci\u00f3n causal del ictus isqu\u00e9mico con la infecci\u00f3n por SARS-CoV-2.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "M\u00c9TODOS"
        },
        {
            "text": "En la Tabla 1 se exponen los datos cl\u00ednicos y complementarios de los cuatro pacientes incluidos (v\u00e9ase tambi\u00e9n el material suplementario: Im\u00e1genes 1-3 y el Anexo I, con la descripci\u00f3n de los casos). Se incluye tambi\u00e9n la etiolog\u00eda del ictus seg\u00fan los criterios TOAST y el \"grado de causalidad\" estimado entre el estado de hipercoagulabilidad asociado a COVID-19 y el ictus isqu\u00e9mico. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "RESULTADOS"
        },
        {
            "text": "La enfermedad COVID-19 aguda tiene 3 fases: infecciosa temprana, pulmonar e hiperinflamatoria grave (7) (8) (9) . En algunos pacientes la respuesta inflamatoria contin\u00faa y se amplifica enormemente, provocando una tormenta de citoquinas y gran participaci\u00f3n de linfocitos T (10), con elevaci\u00f3n de marcadores como interleuquina IL-6, ferritina y prote\u00edna C reactiva, asociados a mayor mortalidad (11). La tormenta de citoquinas provoca disfunci\u00f3n endotelial (9, (12) (13) (14) , que a su vez podr\u00eda verse favorecida por la invasi\u00f3n directa de las c\u00e9lulas endoteliales por el virus, a trav\u00e9s de la interacci\u00f3n entre la prote\u00edna de esp\u00edcula S y los receptores de la ECA2, expresados en el endotelio capilar (15). La disfunci\u00f3n endotelial produce aumento en la s\u00edntesis de trombina y disminuci\u00f3n de la fibrin\u00f3lisis que contribuyen a un estado protromb\u00f3tico, lo cual justifica la alta tasa de complicaciones tromb\u00f3ticas observada en series de pacientes con COVID-19 (8, 16) . De este modo, la elevaci\u00f3n del d\u00edmero-D en estos pacientes se ha propuesto como marcador de hipercoagulabilidad y mal pron\u00f3stico (11, 17) .",
            "cite_spans": [
                {
                    "start": 100,
                    "end": 103,
                    "text": "(7)",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 104,
                    "end": 107,
                    "text": "(8)",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 108,
                    "end": 111,
                    "text": "(9)",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 456,
                    "end": 459,
                    "text": "(9,",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 460,
                    "end": 464,
                    "text": "(12)",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 465,
                    "end": 469,
                    "text": "(13)",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 470,
                    "end": 474,
                    "text": "(14)",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 960,
                    "end": 963,
                    "text": "(8,",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 964,
                    "end": 967,
                    "text": "16)",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 1099,
                    "end": 1103,
                    "text": "(11,",
                    "ref_id": null
                },
                {
                    "start": 1104,
                    "end": 1107,
                    "text": "17)",
                    "ref_id": "BIBREF19"
                }
            ],
            "ref_spans": [],
            "section": "DISCUSI\u00d3N"
        },
        {
            "text": "Respecto al ictus como complicaci\u00f3n tromb\u00f3tica, se ha planteado el estado de hipercoagulabilidad como mecanismo etiopatog\u00e9nico al observarse niveles de d\u00edmero-D m\u00e1s elevados en pacientes con COVID-19 grave (2, 13) . Dicha posibilidad ya se postul\u00f3 en la epidemia del SARS-CoV de 2002-2004, al observarse la aparici\u00f3n de ictus isqu\u00e9mico en pacientes de edad no muy avanzada, con escasos factores de riesgo vascular y enfermedad severa (16) . Aquel coronavirus comparte con el actual SARS-CoV-2 la afinidad por ECA2 (7). Recientemente se han comunicado tres pacientes con COVID-19 grave e ictus isqu\u00e9micos, en los cuales se detectaron anticuerpos antifosfol\u00edpido y alteraciones anal\u00edticas compatibles con inflamaci\u00f3n sist\u00e9mica y coagulopat\u00eda (5). Adem\u00e1s de caracterizar el s\u00edndrome antifosfolip\u00eddico primario, dichos anticuerpos se han detectado en enfermedades inflamatorias sist\u00e9micas e infecciones virales, asoci\u00e1ndose a un mayor riesgo de complicaciones tromboemb\u00f3licas (18) . Asimismo, en pacientes con COVID-19 grave hay que contemplar la posibilidad de otros mecanismos etiopatog\u00e9nicos de ictus isqu\u00e9mico, como cardioembolismos secundarios a da\u00f1o mioc\u00e1rdico o mecanismo hemodin\u00e1mico secundario a shock s\u00e9ptico o cardiog\u00e9nico (16) . La microangiopat\u00eda asociada a disfunci\u00f3n endotelial se ha postulado tambi\u00e9n como mecanismo de isquemia (19) .",
            "cite_spans": [
                {
                    "start": 206,
                    "end": 209,
                    "text": "(2,",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 210,
                    "end": 213,
                    "text": "13)",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 434,
                    "end": 438,
                    "text": "(16)",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 972,
                    "end": 976,
                    "text": "(18)",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 1230,
                    "end": 1234,
                    "text": "(16)",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 1340,
                    "end": 1344,
                    "text": "(19)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "DISCUSI\u00d3N"
        },
        {
            "text": "Entre nuestros pacientes (Tabla 1), el 1 y el 2 se incluyeron en el grupo de alta probabilidad causal, pues presentaban par\u00e1metros anal\u00edticos de inflamaci\u00f3n sist\u00e9mica e hipercoagulabilidad, as\u00ed como un estudio etiol\u00f3gico sin otra causa evidente que justificase el ictus isqu\u00e9mico. El paciente 1 present\u00f3 un infarto cortical sin patolog\u00eda arterial significativa y en ausencia de cardiopat\u00eda embol\u00edgena. En el paciente 2, el ictus ocurri\u00f3 mientras se encontraba ingresado, a pesar de estar en tratamiento con heparina a dosis profil\u00e1cticas. Como se ha mencionado en observaciones previas, estos hallazgos respaldan la hip\u00f3tesis del estado de hipercoagulabilidad como etiolog\u00eda del ictus isqu\u00e9mico en pacientes con COVID-19 con coagulopat\u00eda significativa (2, 5) . Sin embargo, debemos tener en cuenta que los mecanismos del ictus isqu\u00e9mico pueden ser m\u00faltiples y complejos, m\u00e1s a\u00fan en pacientes con situaci\u00f3n cardiorrespiratoria comprometida. Debemos destacar que, debido a la situaci\u00f3n de pandemia actual, en muchas ocasiones se retrasan o no pueden llevarse a cabo todas las pruebas de estudio etiol\u00f3gico (20) . Debido a ello, son necesarios documentos de consenso y adaptaciones de los protocolos vigentes de atenci\u00f3n al ictus, como la reciente publicaci\u00f3n de las Recomendaciones Plan Ictus Madrid (21).",
            "cite_spans": [
                {
                    "start": 752,
                    "end": 755,
                    "text": "(2,",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 756,
                    "end": 758,
                    "text": "5)",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 1104,
                    "end": 1108,
                    "text": "(20)",
                    "ref_id": "BIBREF23"
                }
            ],
            "ref_spans": [],
            "section": "DISCUSI\u00d3N"
        },
        {
            "text": "Las pacientes 3 y 4 se incluyeron en el grupo de baja causalidad por varios motivos. Ten\u00edan en com\u00fan la edad avanzada, m\u00faltiples comorbilidades, el hallazgo casual de la infecci\u00f3n COVID-19 y la etiolog\u00eda m\u00e1s probable del ictus fue cardioemb\u00f3lica. En ambos casos el debut cl\u00ednico fue neurol\u00f3gico, sin evidencia de infecci\u00f3n por SARS-CoV-2 en el momento del ictus. La descripci\u00f3n de estos casos remarca que la coexistencia de ictus isqu\u00e9mico en pacientes con COVID-19 no siempre implica una relaci\u00f3n causal, por lo que el diagn\u00f3stico de infecci\u00f3n por SARS-CoV-2 no debe limitar el estudio etiol\u00f3gico de ictus isqu\u00e9mico (20, 21) .",
            "cite_spans": [
                {
                    "start": 617,
                    "end": 621,
                    "text": "(20,",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 622,
                    "end": 625,
                    "text": "21)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "DISCUSI\u00d3N"
        },
        {
            "text": "En pacientes con COVID-19 que precisen ingreso hospitalario, se ha recomendado la anticoagulaci\u00f3n profil\u00e1ctica con heparina, con incremento de la dosis en pacientes cr\u00edticos y con alto riesgo tromb\u00f3tico (13, 22) . En un reciente estudio, se observ\u00f3 una menor mortalidad en pacientes tratados con dosis profil\u00e1cticas de heparina que presentaban un d\u00edmero-D elevado por encima de 6 veces su l\u00edmite normal (> 3mg/L) y una puntuaci\u00f3n SIC mayor o igual a 4 puntos (13) . Esta puntuaci\u00f3n incluye el tiempo de protrombina, el recuento plaquetario y la escala SOFA y ha sido propuesta como un m\u00e9todo de identificaci\u00f3n precoz de coagulaci\u00f3n intravascular diseminada asociada a sepsis (23) . Sin embargo, en casos de ictus isqu\u00e9mico en pacientes con infecci\u00f3n por SARS-CoV-2 con coagulopat\u00eda y respuesta hiperinflamatoria, el tratamiento precoz con heparina a dosis intermedias o terap\u00e9uticas resulta controvertido, debido al riesgo asociado de transformaci\u00f3n hemorr\u00e1gica (24) . De hecho, actualmente no hay evidencia para recomendar la anticoagulaci\u00f3n precoz (20, 24) , por lo que la decisi\u00f3n se debe individualizar teniendo en cuenta la presencia de estado protromb\u00f3tico y/o inflamaci\u00f3n sist\u00e9mica, la extensi\u00f3n del ictus isqu\u00e9mico y el balance riesgo-beneficio.",
            "cite_spans": [
                {
                    "start": 203,
                    "end": 207,
                    "text": "(13,",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 208,
                    "end": 211,
                    "text": "22)",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 459,
                    "end": 463,
                    "text": "(13)",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 675,
                    "end": 679,
                    "text": "(23)",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 962,
                    "end": 966,
                    "text": "(24)",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 1050,
                    "end": 1054,
                    "text": "(20,",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 1055,
                    "end": 1058,
                    "text": "24)",
                    "ref_id": "BIBREF27"
                }
            ],
            "ref_spans": [],
            "section": "DISCUSI\u00d3N"
        },
        {
            "text": "No debemos pasar por alto las limitaciones que presenta nuestro estudio: la serie de pacientes descrita es peque\u00f1a; la experiencia escasa en la atenci\u00f3n a pacientes con ictus isqu\u00e9mico y COVID-19; la problem\u00e1tica relacionada con el manejo diagn\u00f3stico-terap\u00e9utico que implica la pandemia por SARS-CoV-2; a lo cual se a\u00f1ade la escasa evidencia cient\u00edfica disponible respecto al conocimiento del ictus isqu\u00e9mico en pacientes con COVID-19.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "DISCUSI\u00d3N"
        },
        {
            "text": "El estado de hipercoagulabilidad asociado a la respuesta hiperinflamatoria desencadenada por COVID-19 se podr\u00eda considerar una causa potencial de ictus isqu\u00e9mico. Sin embargo, puesto que los mecanismos etiopatog\u00e9nicos implicados pueden ser m\u00faltiples y complejos, se precisan estudios m\u00e1s amplios que eval\u00faen esta hip\u00f3tesis, as\u00ed como el papel del da\u00f1o endotelial producido por la invasi\u00f3n directa del virus. Mientras tanto, el estudio etiol\u00f3gico del ictus en pacientes con COVID-19 debe ser sistem\u00e1tico y atendiendo a los protocolos vigentes, con las adaptaciones necesarias en relaci\u00f3n con las circunstancias cl\u00ednicas y epidemiol\u00f3gicas de la actual pandemia. Actualmente no existe evidencia para recomendar la anticoagulaci\u00f3n precoz tras un ictus isqu\u00e9mico en pacientes con COVID-19 y par\u00e1metros de hipercoagulabilidad. Son necesarios m\u00e1s estudios, idealmente en forma de ensayos cl\u00ednicos, que aporten evidencias m\u00e1s s\u00f3lidas sobre la indicaci\u00f3n de anticoagulaci\u00f3n en estos pacientes. Entretanto, debemos valorar el balance riesgo-beneficio de forma individualizada.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "CONCLUSIONES"
        },
        {
            "text": "Los autores de este estudio declaran no tener ning\u00fan conflicto de inter\u00e9s.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "CONFLICTOS DE INTER\u00c9S Y FINANCIACI\u00d3N"
        },
        {
            "text": "La presente investigaci\u00f3n no ha recibido ninguna beca espec\u00edfica de agencias de los sectores p\u00fablico, comercial, o sin \u00e1nimo de lucro.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "CONFLICTOS DE INTER\u00c9S Y FINANCIACI\u00d3N"
        },
        {
            "text": "Mat\u00edas-Guiu J, Gomez-Pinedo U, Montero-Escribano P, Gomez-Iglesias P, Porta-Etessam J, Matias-Guiu JA. \u00bfEs esperable que haya cuadros neurol\u00f3gicos por la pandemia por SARS-CoV-2? Neurolog\u00eda. 2020 Apr;35(3):170-5.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "1."
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Mao",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Jin",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "He",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "JAMA Neurol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Neurologic Features in Severe SARS-CoV-2 Infection",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Helms",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kremer",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Merdji",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Clere-Jehl",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Schenck",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Kummerlen",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Manual COVID-19 para el neur\u00f3logo general",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Ezpeleta",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "G"
                    ],
                    "last": "Azor\u00edn",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Xiao",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Xia",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Adams",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Bendixen",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Kappelle",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Biller",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Love",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Gordon",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "Stroke",
            "volume": "24",
            "issn": "",
            "pages": "35--41",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Influencia de la infecci\u00f3n SARS-Cov2 sobre Enfermedades Neurodegenerativas y Neuropsiqui\u00e1tricas: \u00bfUna pandemia demorada? Neurolog\u00eda",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "J"
                    ],
                    "last": "Serrano-Castro",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Estivill-Torr\u00fas",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Cabezudo-Garc\u00eda",
                    "suffix": ""
                },
                {
                    "first": "Antonio",
                    "middle": [],
                    "last": "Reyes-Bueno",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Petersen",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "C"
                    ],
                    "last": "Aguilar-Castillo",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "COVID-19 and the Heart",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Akhmerov",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Marban",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Circulation Research",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Channappanavar",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Perlman",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Semin Immunopathol",
            "volume": "39",
            "issn": "5",
            "pages": "529--568",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Prompetchara",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Ketloy",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Palaga",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Asian Pac J Allergy Immunol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Du",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Fan",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "395",
            "issn": "",
            "pages": "1054--62",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Mcgonagle",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Sharif",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "O&apos;regan",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Bridgewood",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Autoimmunity Reviews",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Tang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Bai",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Gong",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Thromb Haemost",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Tissue Plasminogen Activator (tPA) Treatment for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS): A Case Series",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Hajizadeh",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "E"
                    ],
                    "last": "Moore",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "C"
                    ],
                    "last": "Mcintyre",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "K"
                    ],
                    "last": "Moore",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "A"
                    ],
                    "last": "Veress",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Thromb Haemost",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Endothelial cell infection and endotheliitis in COVID-19. The Lancet",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Varga",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "J"
                    ],
                    "last": "Flammer",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Steiger",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Haberecker",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Andermatt",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Zinkernagel",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Large artery ischaemic stroke in severe acute respiratory syndrome (SARS)",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Umapathi",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Kor",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Venketasubramanian",
                    "suffix": ""
                },
                {
                    "first": "Cct",
                    "middle": [],
                    "last": "Lim",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "C"
                    ],
                    "last": "Pang",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "T"
                    ],
                    "last": "Yeo",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Neurol",
            "volume": "251",
            "issn": "10",
            "pages": "1227--1258",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Tang",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Thromb Haemost",
            "volume": "18",
            "issn": "4",
            "pages": "844--851",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis. Lupus",
            "authors": [
                {
                    "first": "Abdel-Wahab N",
                    "middle": [],
                    "last": "Talathi",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lopez-Olivo",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Suarez-Almazor",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "E"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "",
            "volume": "27",
            "issn": "",
            "pages": "572--83",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Elevated Troponin in Patients With Coronavirus Disease 2019: Possible Mechanisms",
            "authors": [],
            "year": 2020,
            "venue": "Journal of Cardiac Failure",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Challenges and Potential Solutions of Stroke Care During the Coronavirus Disease 2019 (COVID-19) Outbreak. Stroke",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Rudd",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Atenci\u00f3n al ictus agudo durante la pandemia por COVID-19. Recomendaciones Plan Ictus Madrid",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Rodr\u00edguez-Pardo",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Fuentes",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "De Leci\u00f1ana",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Campollo",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "C"
                    ],
                    "last": "Casta\u00f1o",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Ruiz",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1161/STROKEAHA.120.02970121"
                ]
            }
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Incidence of thrombotic complications in critically ill ICU patients with COVID-19",
            "authors": [
                {
                    "first": "F",
                    "middle": [
                        "A"
                    ],
                    "last": "Klok",
                    "suffix": ""
                },
                {
                    "first": "Mjha",
                    "middle": [],
                    "last": "Kruip",
                    "suffix": ""
                },
                {
                    "first": "Njm",
                    "middle": [],
                    "last": "Van Der Meer",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "S"
                    ],
                    "last": "Arbous",
                    "suffix": ""
                },
                {
                    "first": "Dampj",
                    "middle": [],
                    "last": "Gommers",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "M"
                    ],
                    "last": "Kant",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Thrombosis Research",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Iba",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Levy",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "E"
                    ],
                    "last": "Warkentin",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Thachil",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Poll",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Levi",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "J Thromb Haemost",
            "volume": "17",
            "issn": "11",
            "pages": "1989--94",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Guidelines for the Early Management of Patients With Acute Ischemic Stroke",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "J"
                    ],
                    "last": "Powers",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Rabinstein",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Ackerson",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [
                        "M"
                    ],
                    "last": "Adeoye",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "C"
                    ],
                    "last": "Bambakidis",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Becker",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "TABREF0": {
            "text": "Escala de ictus de los Institutos Nacionales de la Salud de EEUU RT-PCR: Reacci\u00f3n en cadena de la polimerasa con transcripci\u00f3n inversa SARS: S\u00edndrome Respiratorio Agudo Grave SARS-CoV: Coronavirus del s\u00edndrome respiratorio agudo grave SARS-CoV-2: Coronavirus 2 (coronavirus-2019) del s\u00edndrome respiratorio agudo grave SIC: Coagulopat\u00eda inducida por sepsis SOFA: Evaluaci\u00f3n del fallo org\u00e1nico secuencial TOAST: Ensayo de Org 10172 como Tratamiento del Ictus Agudo UCI: Unidad de Cuidados Intensivos",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "TABLA 1 -Variables descriptivas de los pacientes con ictus isqu\u00e9mico y COVID-19",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": "2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke [Internet] . 2019 Dec [cited 2020 Apr 18] ;50 (12) . Available from: https://www.ahajournals.org/doi/10.1161/STR.0000000000000211Imagen 1 -Estudio de perfusi\u00f3n cerebral. Se evidencia una hipoperfusi\u00f3n en territorios M2-M5 de la arteria cerebral media izquierda, con aumento del tiempo de tr\u00e1nsito medio y sin datos de \u00e1rea de infarto (penumbra isqu\u00e9mica 100%).Imagen 2 -TC de cr\u00e1neo de control 24 horas tras el debut neurol\u00f3gico. A: corte bajo a nivel infratentorial; B: corte m\u00e1s alto a nivel supratentorial. Se aprecia hipodensidad parenquimatosa en hemisferio cerebeloso izquierdo, giros occipitotemporales izquierdos y giro hipocampal izquierdo.Imagen 3 -TC de t\u00f3rax al ingreso. A: corte a nivel de l\u00f3bulos superiores. B: corte a nivel de l\u00f3bulos inferiores. Se observan opacificaciones en vidrio deslustrado bilaterales de predominio derecho. Presentan distribuci\u00f3n central y sobre todo perif\u00e9rica. Tambi\u00e9n existen consolidaciones parenquimatosas que afectan al l\u00f3bulo superior derecho, as\u00ed como un derrame pleural derecho moderado.",
            "cite_spans": [
                {
                    "start": 199,
                    "end": 209,
                    "text": "[Internet]",
                    "ref_id": null
                },
                {
                    "start": 233,
                    "end": 240,
                    "text": "Apr 18]",
                    "ref_id": null
                },
                {
                    "start": 245,
                    "end": 249,
                    "text": "(12)",
                    "ref_id": "BIBREF11"
                }
            ],
            "ref_spans": [],
            "section": "annex"
        }
    ]
}